By Rebecca Robbins and Christina Jewett from NYT Health https://ift.tt/3rTvXwn
via IFTTT The C.D.C. recommends that other vaccines be preferred over J.&J. The agency’s advisers cited concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot. Health New York Times December 15, 2021 at 06:00PM
No comments:
Post a Comment